203 related articles for article (PubMed ID: 31114851)
1. Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor.
Henon C; Blay JY; Massard C; Mir O; Bahleda R; Dumont S; Postel-Vinay S; Adam J; Soria JC; Le Cesne A
Ann Oncol; 2019 Aug; 30(8):1401-1403. PubMed ID: 31114851
[No Abstract] [Full Text] [Related]
2. Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: A case report.
Takada K; Sugita S; Murase K; Kikuchi T; Oomori G; Ito R; Hayasaka N; Miyanishi K; Iyama S; Ikeda H; Kobune M; Emori M; Kato J; Hasegawa T
Thorac Cancer; 2019 Dec; 10(12):2312-2315. PubMed ID: 31617320
[TBL] [Abstract][Full Text] [Related]
3. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
[TBL] [Abstract][Full Text] [Related]
4. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.
Crombé A; Alberti N; Villard N; Pilleul F; Buy X; Le Loarer F; Kind M
Eur Radiol; 2019 Sep; 29(9):4730-4741. PubMed ID: 30762113
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities.
Yoshida A; Kobayashi E; Kubo T; Kodaira M; Motoi T; Motoi N; Yonemori K; Ohe Y; Watanabe SI; Kawai A; Kohno T; Kishimoto H; Ichikawa H; Hiraoka N
Mod Pathol; 2017 Jun; 30(6):797-809. PubMed ID: 28256572
[TBL] [Abstract][Full Text] [Related]
6. SMARCA4-Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression.
Masliah-Planchon J; Machet MC; Fréneaux P; Jourdain A; Mortemousque I; Raïs KA; Ballet S; Jouvet A; Figarella-Branger D; Delattre O; Bourdeaut F
Pediatr Blood Cancer; 2016 Mar; 63(3):568-9. PubMed ID: 26469284
[No Abstract] [Full Text] [Related]
7. Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.
Iijima Y; Sakakibara R; Ishizuka M; Honda T; Shirai T; Okamoto T; Tateishi T; Sakashita H; Tamaoka M; Takemoto A; Kumaki Y; Ikeda S; Miyazaki Y
Immunotherapy; 2020 Jun; 12(8):563-569. PubMed ID: 32363992
[TBL] [Abstract][Full Text] [Related]
8. SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis.
Hasselblatt M; Nagel I; Oyen F; Bartelheim K; Russell RB; Schüller U; Junckerstorff R; Rosenblum M; Alassiri AH; Rossi S; Schmid I; Gottardo NG; Toledano H; Viscardi E; Balbin M; Witkowski L; Lu Q; Betts MJ; Foulkes WD; Siebert R; Frühwald MC; Schneppenheim R
Acta Neuropathol; 2014 Sep; 128(3):453-6. PubMed ID: 25060813
[No Abstract] [Full Text] [Related]
9. Thoracic SMARCA4-deficient undifferentiated tumors mimicking inflammatory lesions.
Ma P; Cheng A; Song F; Sun Y
Asian J Surg; 2024 May; 47(5):2290-2291. PubMed ID: 38331614
[No Abstract] [Full Text] [Related]
10. Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.
Chatzopoulos K; Boland JM
Virchows Arch; 2021 Jan; 478(1):21-30. PubMed ID: 33409598
[TBL] [Abstract][Full Text] [Related]
11. SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources.
Kuwamoto S; Matsushita M; Takeda K; Tanaka N; Endo Y; Yamasaki A; Kohashi K; Oda Y; Horie Y
Hum Pathol; 2017 Dec; 70():92-97. PubMed ID: 28601660
[TBL] [Abstract][Full Text] [Related]
12. When Cold Is Hot: Immune Checkpoint Inhibition Therapy for Rhabdoid Tumors.
Yarmarkovich M; Maris JM
Cancer Cell; 2019 Dec; 36(6):575-576. PubMed ID: 31951557
[TBL] [Abstract][Full Text] [Related]
13. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates.
Mei L; Alikhan M; Mujacic I; Parilla M; Antic T
Acta Cytol; 2019; 63(5):438-444. PubMed ID: 31230044
[TBL] [Abstract][Full Text] [Related]
14. Thoracic SMARCA4-deficient undifferentiated tumor: current knowledge and future perspectives.
Shinno Y; Ohe Y;
Jpn J Clin Oncol; 2024 Mar; 54(3):265-270. PubMed ID: 38117955
[TBL] [Abstract][Full Text] [Related]
15. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.
Le Loarer F; Watson S; Pierron G; de Montpreville VT; Ballet S; Firmin N; Auguste A; Pissaloux D; Boyault S; Paindavoine S; Dechelotte PJ; Besse B; Vignaud JM; Brevet M; Fadel E; Richer W; Treilleux I; Masliah-Planchon J; Devouassoux-Shisheboran M; Zalcman G; Allory Y; Bourdeaut F; Thivolet-Bejui F; Ranchere-Vince D; Girard N; Lantuejoul S; Galateau-Sallé F; Coindre JM; Leary A; Delattre O; Blay JY; Tirode F
Nat Genet; 2015 Oct; 47(10):1200-5. PubMed ID: 26343384
[TBL] [Abstract][Full Text] [Related]
16. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
Bookhout C; Bouldin TW; Ellison DW
Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
[TBL] [Abstract][Full Text] [Related]
17. Innocuous clinical presentation of a SMARCA4-deficient thoracic sarcoma arising in a patient with chronic empyema thoracis.
Nambirajan A; Parshad R; Goyal A; N K M; Jain D
Pathology; 2019 Oct; 51(6):657-659. PubMed ID: 31470991
[No Abstract] [Full Text] [Related]
18. Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again.
Witkowski L; Lalonde E; Zhang J; Albrecht S; Hamel N; Cavallone L; May ST; Nicholson JC; Coleman N; Murray MJ; Tauber PF; Huntsman DG; Schönberger S; Yandell D; Hasselblatt M; Tischkowitz MD; Majewski J; Foulkes WD
J Pathol; 2013 Sep; 231(1):35-43. PubMed ID: 23775540
[TBL] [Abstract][Full Text] [Related]
19. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors.
Matsushita M; Kuwamoto S
Acta Cytol; 2018; 62(5-6):456-462. PubMed ID: 30286456
[TBL] [Abstract][Full Text] [Related]
20. Rhabdoid tumor predisposition syndrome.
Sredni ST; Tomita T
Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
